Blood

Up-front blinatumomab improves MRD clearance and outcome in adult Ph- B-lineage ALL: The GIMEMA LAL2317 phase 2 study

American Journal of Clinical Oncology

Impact of minimal residual diseases status and depth of response on survival outcomes in blinatumomab-treated acute lymphoblastic leukemia: A systematic review and meta-analysis

Journal Of Pediatric Health Care

Changes in symptom clusters over the course of chemotherapy in children with acute lymphoblastic leukemia: A longitudinal survey

Haematologica

Acute therapy-related toxicities in pediatric acute lymphoblastic leukemia

Pharmacotherapy

Evaluation of methotrexate pharmacogenomic variation to predict acute neurotoxicity in children with acute lymphoblastic leukemia

BMC Health Services Research

Exploring the financial burden of pediatric bone marrow transplantation: A cross-sectional study from the caregiver's viewpoint

American Journal of Clinical Oncology

A meta-analysis on effects of chimeric antigen receptor T-cell therapy in relapsed or refractory B-cell acute lymphoblastic leukemia

European Journal of Pediatrics

Quality of life trajectories in children aged 2-4 years with acute lymphoblastic leukemia

Blood

Daratumumab in pediatric relapsed/refractory acute lymphoblastic leukemia or lymphoblastic lymphoma: The DELPHINUS study

Expert Review of Hematology

Characterizing the ideal patient for treatment with inotuzumab ozogamicin for relapsed/refractory acute lymphoblastic leukemia: A systematic literature review